Aligned Genetics, Inc.

KOSDAQ:A238120 Lagerbericht

Marktkapitalisierung: ₩47.3b

Aligned Genetics Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Yeon-Cheol Jung

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführers20.5%
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitgliederkeine Daten

Jüngste Management Updates

Recent updates

Aligned Genetics, Inc.'s (KOSDAQ:238120) Shareholders Might Be Looking For Exit

Nov 20
Aligned Genetics, Inc.'s (KOSDAQ:238120) Shareholders Might Be Looking For Exit

Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

Aug 12
Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Apr 06
If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Feb 11
Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Geschäftsführer

Yeon-Cheol Jung (54 yo)

no data

Amtszeit

Mr. Yeon-Cheol Jung serves as the Chief Executive Officer at Aligned Genetics, Inc. (formerly known as Logos Biosystems, Inc.). Mr. Jung is an Insider at Aligned Genetics, Inc. (formerly known as Logos Bio...